You are here

  • Home
  • Archive
  • Volume 2017, Issue
  • Cortical blindness as a rare presentation of hemorrhagic cerebral hyperperfusion syndrome following vertebral angioplasty

Article Text

Article menu
Download PDFPDF
Ischemic Stroke
CASE REPORT
Cortical blindness as a rare presentation of hemorrhagic cerebral hyperperfusion syndrome following vertebral angioplasty
  1. Chao Fu1,
  2. Zhongxin Xu2,
  3. Zhenzhen Hu3,
  4. Shuai Yao2,
  5. Fengmin Liu1,
  6. Baiqi Feng4,
  7. Conghai Zhao1,
  8. Weidong Yu1
  1. 1Department of Neurosurgery, China-Japan Union Hospital of Jilin University, Changchun, China
  2. 2Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China
  3. 3Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun, China
  4. 4Department of Neurosurgery, Qianguo County Hospital, Songyuan, China
  1. Correspondence to Dr Weidong Yu, fc616{at}126.com

Summary

Cerebral hyperperfusion syndrome (CHS) is a well-documented complication after carotid endarterectomy or stenting. In contrast, CHS following vertebral revascularization is extremely rare. Here we present a case of a 77-year-old man with high-grade vertebral stenosis who subsequently underwent balloon angioplasty, complicated by hemorrhagic CHS manifesting as cortical blindness, although strict postoperative blood pressure control was administered. To our knowledge, cortical blindness as a presentation of hemorrhagic CHS has not previously been reported. This study highlights the fact that identifying high-risk patients, as well as making an individual therapeutic plan, is important prior to revascularization. Further studies are needed to elucidate the exact mechanism of this condition and thereby prevent it.

  • angioplasty
  • complication
  • stenosis

https://doi.org/10.1136/bcr-2017-013412

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors CF, ZX, CZ, and WY diagnosed and treated the patient. CF, ZH, SY, BF, and WY designed the study, interpreted the data, and wrote the manuscript. CF, ZX, FL, CZ, and WY revised the manuscript.

    • Competing interests None declared.

    • Patient consent Obtained.

    • Ethics approval Ethics Committee of the China-Japan Union Hospital of Jilin University.

    • Provenance and peer review Not commissioned; externally peer reviewed.